These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25061884)

  • 1. Association between polymorphisms in the TSHR gene and Graves' orbitopathy.
    Jurecka-Lubieniecka B; Ploski R; Kula D; Szymanski K; Bednarczuk T; Ambroziak U; Hasse-Lazar K; Hyla-Klekot L; Tukiendorf A; Kolosza Z; Jarzab B
    PLoS One; 2014; 9(7):e102653. PubMed ID: 25061884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.
    Gong J; Jiang SJ; Wang DK; Dong H; Chen G; Fang K; Cui JR; Lu FE
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):473-479. PubMed ID: 27465319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Davies TF
    Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis.
    Xiong H; Wu M; Yi H; Wang X; Wang Q; Nadirshina S; Zhou X; Liu X
    Sci Rep; 2016 Jul; 6():30356. PubMed ID: 27456991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of chosen polymorphisms rs2476601 a/G - PTPN22, rs1990760 C/T - IFIH1, rs179247 a/G - TSHR in pathogenesis of autoimmune thyroid diseases in children.
    Rydzewska M; Góralczyk A; Gościk J; Wawrusiewicz-Kurylonek N; Bossowska A; Krętowski A; Bossowski A
    Autoimmunity; 2018 Jun; 51(4):183-190. PubMed ID: 29973096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
    Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
    [No Abstract]   [Full Text] [Related]  

  • 10. Current insights into the pathogenesis of Graves' orbitopathy.
    Eckstein AK; Johnson KT; Thanos M; Esser J; Ludgate M
    Horm Metab Res; 2009 Jun; 41(6):456-64. PubMed ID: 19530272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan.
    Liao WL; Wan L; Wang TY; Chen CC; Tse SS; Lu CH; Tsai FJ
    BMC Ophthalmol; 2014 Feb; 14():15. PubMed ID: 24517461
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
    Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
    Zhou F; Liang Z; Wang X; Tan G; Wei W; Zheng G; Ma X; Tian D; Li H; Yu H
    Gene; 2021 Aug; 793():145750. PubMed ID: 34077777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
    Li Y; Luo B; Tong B; Xie Z; Cao J; Bai X; Peng Y; Wu Y; Wang W; Qi X
    J Endocrinol Invest; 2023 Feb; 46(2):305-317. PubMed ID: 35986869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.
    Syed AA; Simmonds MJ; Brand OJ; Franklyn JA; Gough SC; Heward JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):663-7. PubMed ID: 17608818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients.
    Han SZ; Zhang SH; Li R; Zhang WY; Li Y
    Int J Immunogenet; 2006 Aug; 33(4):281-7. PubMed ID: 16893393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
    Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
    Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.